Oscar Health Inc.
OSCR | NYSE
$29.98
-$1.31 (-4.19%)
Sep 22, 2026, 12:06 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 11.7B | 9.18B | 5.86B | 4.13B | 1.92B | 589.64M |
Cost of Revenue | 10.02B | 7.33B | 4.64B | n/a | n/a | n/a |
Gross Profit | 1.68B | 1.84B | 1.22B | 4.13B | 1.92B | 589.64M |
Operating Income | -396.36M | 57.27M | -235.62M | -610.08M | -570.58M | -405.78M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -437.3M | 33.43M | -267.3M | -610.08M | -570.58M | -405.78M |
Net Income | -443.15M | 25.43M | -270.73M | -606.28M | -572.61M | -406.83M |
Selling & General & Admin | 2.05B | n/a | n/a | 1.42B | 265.08M | 166.66M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 28.89M | 1.79B | 1.46B | 3.32B | 2.23B | 828.77M |
Operating Expenses | 2.08B | 1.79B | 1.46B | 4.74B | 2.49B | 995.42M |
Interest Expense | 17.6M | 23.73M | 24.6M | 22.62M | 4.72M | 3.51M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.1B | 9.12B | 6.1B | 4.74B | 2.49B | 995.42M |
Income Tax Expense | 5.61M | 7.31M | 3.29M | -523K | 846K | 1.05M |
Shares Outstanding (Basic) | 262.39M | 240.39M | 221.66M | 212.47M | 178.97M | 239.31M |
Shares Outstanding (Diluted) | 262.39M | 265.85M | 221.66M | 212.47M | 178.97M | 239.31M |
EPS (Basic) | -1.69 | 0.11 | -1.22 | -2.85 | -3.19 | -1.70 |
EPS (Diluted) | -1.69 | 0.10 | -1.22 | -2.85 | -3.19 | -1.70 |
EBITDA | -391.05M | 89.31M | -212M | -572.17M | -551.26M | -390.98M |
EBIT | -419.7M | 57.16M | -242.7M | -587.45M | -565.86M | -402.27M |
Depreciation & Amortization | 28.89M | 32.15M | 30.69M | 15.28M | 14.61M | 11.29M |
Add to Watchlist
Select watchlists to add or remove OSCR